SecBot SecBot
SC 13G/A ·Filed Nov 13, 2026

ADCT

ADC Therapeutics SA
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 7h ago SEC0001617201-26-000007
Passive stake amendment
Actionable Insight • Neutral

The stake is too small to signal conviction or influence. Monitor for any future increases that could indicate a larger position or a potential conversion to an activist 13D filing.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Prosight Management, LP filed an amended Schedule 13G disclosing a passive stake of 0.31% (399,900 shares) in ADC Therapeutics as of September 30, 2026. This is a new filing by a different investor compared to the prior 9.99% stake from Bain Capital, and the stake is very small relative to the company's market cap.

Key Financial Metrics

Stake
0.31%
Stake Value
$632.4K
Investor
Prosight Management, LP
Investor Type
hedge fund

Key Facts

  • Prosight Management, LP disclosed beneficial ownership of 399,900 common shares of ADC Therapeutics as of September 30, 2026.
  • The stake represents 0.31% of shares outstanding based on 127,667,695 shares as of August 3, 2026.
  • This is an amendment to a Schedule 13G filed under Rule 13d-1(c), indicating a passive investment intent.
  • The filing is by a new filer (Prosight Management), not an update to the prior Bain Capital or Redmile Group stakes.

Financial Impact

Stake value approximately $0.6M based on $204M market cap and 0.31% ownership.

ownership

Risk Factors

  • No material risks identified from this filing alone.

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
67% bullish (12 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
SC 13G/A Filing (Primary)0001617201-26-000007
Document: 0001617201-26-000007-index.html0001617201-26-000007
Document: 0001617201-26-000007.txt0001617201-26-000007

Track record

14 reports on ADCT

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 13, 20263d ago SC 13G/A Neutral 2/10 Viewing Entry $1.41 Now $1.25 −11.35% settles Dec 15
  2. Nov 9, 20267d ago S-3 Neutral 3/10 Entry $1.51 Now $1.25 −17.22% settles Dec 9
  3. Nov 9, 20267d ago 8-K Neutral 4/10 Entry $1.67 Now $1.25 −25.15% settles Dec 8
  4. Nov 4, 202612d ago 8-K Mixed 6/10 Entry $1.64 Now $1.25 −23.78% settles Dec 4
  5. Nov 3, 202613d ago S-4 Neutral 3/10 Entry $1.72 Now $1.25 −27.33% settles Dec 3
  6. Oct 29, 202618d ago SC 13G Neutral 4/10 Entry $1.53 Now $1.25 −18.30% settles Nov 30
  7. Oct 13, 20264w ago 8-K Bullish 7/10 Entry $1.70 to $1.51 Now $1.25 −26.47% ▼ −11.18% −7.57% vs SPY
  8. Aug 6, 202614w ago Press Release Neutral 1/10 Entry $1.13 to $1.32 Now $1.25 +10.62% ▲ +16.81% +16.21% vs SPY
  9. Jul 2, 202619w ago 8-K Neutral 2/10 Entry $1.19 to $1.11 Now $1.25 +5.04% ▼ −6.72% −6.31% vs SPY
  10. Jun 3, 202623w ago 8-K Mixed 6/10 Entry $1.32 to $1.19 Now $1.25 −5.30% ▼ −9.85% −8.48% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 8h 17m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026